McKesson reorganizes its biopharma services

Seeking to highlight how “the business has evolved to meet the industry’s need for a best-in-class and integrated portfolio of commercialization, launch and in-market solutions,” McKesson has relaunched its biopharmaceutical services business under its US Pharmaceutical and Specialty Health business […]

Read More

A Conversation with Rafik Bishara

After a long tenure at Eli Lilly and Company, Rafik Bishara, PhD, entered a new phase in his career: a globally recognized authority on how the transportation, storage and distribution practices of the global pharma industry are defined and regulated. […]

Read More